PRIYA CHADDAH: Open Payments
NPI 1407480643 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 14 payments from 6 companies in 2025. Trend: 2023 $532 · 2024 $447 · 2025 $713
Food & beverage: $613Education: $100
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 7 | $370 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $147 |
| Mallinckrodt Hospital Products Inc. | 2 | $123 |
| Novo Nordisk Inc | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Travere Therapeutics, Inc. | 1 | $8 |
Products named: XPHOZAH 30 MG, JARDIANCE, IBSRELA, ACTHAR, Wegovy, Vanrafia.
Industry payments across VA — which companies pay providers there.
